Study guide

3.1 Unlawful Conduct, Criminal Penalties, Fines & the Disciplinary Process

Utah MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Utah Pharmacy Regulatory Framework, Facility Licensing & the PIC

1.1 DOPL, the Utah State Board of Pharmacy & the Sources of Utah Pharmacy Law 1.2 Federal vs. Utah Law: Following the Stricter Standard 1.3 Utah Pharmacy License Classes (A–E) & Facility Licensing 1.4 The Pharmacist-in-Charge (PIC): Duties, Self-Audits & Notifications 1.5 Facility Inspections, Ownership & Location Changes, Closing & Facility Discipline

2 Chapter 2: Pharmacist, Intern & Technician Licensure and Personnel

2.1 Pharmacist Licensure, the NAPLEX & Utah MPJE, and Licensure by Endorsement 2.2 License Renewal, Continuing Education & Reinstatement 2.3 Pharmacy Interns & Preceptors 2.4 Pharmacy Technicians, Technician Trainees & Supportive Personnel

3 Chapter 3: Unlawful & Unprofessional Conduct, Discipline, and Impairment

3.1 Unlawful Conduct, Criminal Penalties, Fines & the Disciplinary Process 3.2 Unprofessional Conduct, the APhA Code of Ethics & Utah's Conscience Law 3.3 Impairment, the Utah Professionals Health Program & Reinstatement

4 Chapter 4: Prescription Issuance, Prescriber Authority & Electronic Prescribing

4.1 Prescriber Scope of Authority in Utah 4.2 Required Prescription Elements, Oral & Faxed Orders, and Alterations 4.3 Mandatory Electronic Prescribing of Controlled Substances (EPCS) in Utah 4.4 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags

5 Chapter 5: Patient Counseling, Prospective DUR, Confidentiality & Records

5.1 Patient Counseling: The Offer, Who May Counsel & Delivered Prescriptions 5.2 Prospective Drug Utilization Review & Patient Medication Profiles 5.3 Confidentiality, HIPAA & Protected Health Information 5.4 Pharmacy Records, Retention Periods & Facility Operating Standards

6 Chapter 6: Expanded Practice: Collaboration, Pharmacist Prescribing & Drug Administration

6.1 Collaborative Pharmacy Practice, Drug Therapy Management & Administration of Drugs 6.2 Self-Administered Hormonal Contraception: Standing Order & Pharmacist Prescribing 6.3 Pharmacist Prescribing Under Utah Code § 58-17b-627: Tobacco Cessation, HIV PrEP/PEP, Fluoride & Epinephrine 6.4 Vaccine Administration: DOPL's Protocol, Delegation, Emergencies & USIIS Reporting

7 Chapter 7: Opioid Overdose Prevention, Emergency Refills & Returned or Donated Drugs

7.1 Naloxone & Opioid-Safety Laws in Utah 7.2 Emergency Refills, Combined Refills & Insulin Continuity 7.3 Returned Drugs, Consumer Disposal & the Charitable Prescription Drug Recycling Program

8 Chapter 8: Controlled Substance Schedules, Registration & Security in Utah

8.1 Controlled Substance Schedules: Federal CSA & Utah-Specific Scheduling 8.2 DEA Registration & Facility Licensing 8.3 Controlled Substance Storage & Physical Security

9 Chapter 9: Dispensing Controlled Substances & the Utah Controlled Substance Database

9.1 Schedule II Prescriptions: 30-Day Window, One-Month Supply, Multiple Prescriptions & the 7-Day Acute Limit 9.2 Schedule II Partial Fills, Emergency Oral Orders & Methadone Emergency Orders 9.3 Schedule III–V Prescriptions: Refill Limits, the 80% Rule & Controlled Substance Transfers 9.4 The Utah Controlled Substance Database (CSD)

10 Chapter 10: Dispensing Standards: Labeling, Substitution, Refills, Packaging, Product Integrity & OTC Products

10.1 Prescription Labels: Utah Minimum Elements, Controlled Substance & Opioid Warnings, and Special Labels 10.2 Drug Product Selection: Generic Equivalents, Therapeutically Similar Drugs & Interchangeable Biologics 10.3 Legend-Drug Prescription Validity, Refills & Transfers 10.4 Poison Prevention Packaging Act (PPPA) & Special Packaging 10.5 Drug Product Conditions That Prohibit Dispensing: Adulterated, Misbranded, Outdated, Recalled & Suspect Products 10.6 Nonprescription Products: OTC Labeling & Packaging, Pseudoephedrine, Iodine, Schedule V & Other Restricted OTC Sales

11 Chapter 11: Acquisition, Inventory, Loss, Distribution & Delivery

11.1 Ordering Schedule II Substances: DEA Form 222 & CSOS 11.2 Controlled Substance Inventories & Utah's Schedule II Perpetual Inventory 11.3 Theft, Significant Loss & Disposal of Controlled Substances 11.4 Drug Acquisition & Distribution, Office-Use Sales, and Delivering Prescriptions to Patients

12 Chapter 12: Compounding Standards, USP Chapters & Hazardous Drugs

12.1 Non-Sterile Compounding & USP <795> Standards 12.2 Sterile Compounding & USP <797> Standards 12.3 Hazardous Drug Handling & USP <800> Standards

13 Chapter 13: Institutional, Central Processing, Remote Dispensing, Specialty Outlets & Automation

13.1 Institutional Practice: Hospitals, Pharmaceutical Administration Facilities & Emergency Drug Kits 13.2 Centralized Prescription Processing, Telepharmacy & Remote Dispensing Pharmacies 13.3 Nuclear Pharmacies, Class E Outlets & Dispensing Medical Practitioners 13.4 Automated Pharmacy Systems, Quality Assurance & Pharmacy Audits

3.1 Unlawful Conduct, Criminal Penalties, Fines & the Disciplinary Process

Key Takeaways Explain This Topic AI

Practicing pharmacy without a license, and filling prescriptions for Utah residents without the required license, are third degree felonies (Utah Code § 58-17b-504(1)).

Most other unlawful conduct under § 58-17b-501, such as buying or selling drug samples, is a class A misdemeanor (Utah Code § 58-17b-504(2)).

DOPL may fine up to $10,000 per violation or $2,000 per day of ongoing violation under the pharmacy chapter, using the fine schedule in R156-17b-402.

In a formal hearing the licensing board usually acts as fact finder and issues a recommended order; the DOPL director issues the final order (Utah Code § 58-1-109).

A director's final order may be appealed by filing a request for agency review with the executive director of the Department of Commerce (Utah Code § 58-1-109(8)).

Last updated: September 2026

3.1 Unlawful Conduct, Criminal Penalties, Fines & the Disciplinary Process

Area 1 of the blueprint includes "classifications and processes of disciplinary actions." Utah law uses two categories:

Unlawful conduct: acts defined as unlawful in Title 58. They can be prosecuted as crimes and also disciplined administratively.

Unprofessional conduct: conduct by a licensee or applicant that violates professional standards, statutes, or rules. It leads to license discipline and fines (see Section 3.2).

Unlawful conduct in the DOPL Act (§ 58-1-501(1))

For every Title 58 profession, unlawful conduct includes:

practicing, or attempting or claiming to practice, without a license or exemption, or beyond a suspended, revoked, restricted, temporary, probationary, or inactive license;

  • impersonating another licensee or practicing under a false name;
  • knowingly employing an unlicensed person to do work that requires a license;
  • letting someone else use your license;
  • using fraud or deception to pass an exam, obtain a license, or deal with DOPL or a board;

issuing a prescription to a person in Utah without prescriptive authority (or, under an exception or multistate privilege, without first gathering enough information for a diagnosis); and

aiding or abetting another person to violate a licensing statute, rule, or order.

Unlawful conduct in the Pharmacy Practice Act (§ 58-17b-501)

  • # Unlawful conduct
  • 1 Knowingly preventing or refusing a DOPL inspection
  • 2 Failing to return a revoked, suspended, or refused license or certificate when DOPL demands it

3 Using the title "pharmacist", "druggist", "pharmacy intern", or "pharmacy technician" without the license, or a business name with "pharmacy", "drugstore", "apothecary", "prescriptions", and similar words unless it is a licensed pharmacy (stores may display "packaged drugs", "drug sundries", or "nonprescription drugs")

4 Buying, selling, or offering for sale a drug or device marked "sample" , "not for resale", or "for investigational use only" (except costs incurred in the bona fide acquisition of an investigational drug)

5 Using or revealing trade secrets or information obtained under the chapter, except to DOPL, the board, or a court

6 Obtaining a drug, or having someone else obtain it, by fraud, forgery or alteration of a prescription, concealment, false statement, or theft

7 Filling or advertising the filling of prescriptions for Utah residents without a license under this chapter or in the dispensing state

  • 8 Requiring an employed pharmacist, intern, technician, or supportive staff member to violate the chapter
  • 9 Possessing a prescription drug for an unlawful purpose

10 Dispensing a prescription drug to a person who has no prescription, except as allowed by the Treatment Access statutes (Title 26B, Chapter 4, Part 5)

  • 11 Dispensing to someone you know or should know is trying to obtain drugs by fraud or misrepresentation
  • 12 Selling, dispensing, distributing, or trafficking prescription drugs without a license or exemption
  • 13 Using a prescription drug or controlled substance that was not lawfully prescribed to you
  • Criminal penalties (§ 58-17b-504(1)–(2))

Offense Penalty

Unlicensed practice (§ 58-1-501(1)(a)(i)); filling prescriptions for Utah residents without a license (§ 58-17b-501(7)); dispensing to someone you know or should know is committing fraud (§ 58-17b-501(11)) Third degree felony

Other § 58-1-501(1) violations and the remaining § 58-17b-501 violations Class A misdemeanor

A licensee who has already been convicted of a § 58-17b-501 offense may not also be fined administratively for the same offense (§ 58-17b-504(4)).

Administrative sanctions and fines

Under § 58-17b-401 and § 58-1-401, DOPL may refuse to issue or renew a license, or revoke, suspend, restrict, place on probation, reprimand (publicly or privately), issue cease and desist orders, and impose fines or citations. A license revoked or suspended under § 58-1-401 generally cannot be reinstated for at least 90 days unless DOPL and the board impose other conditions (§ 58-1-403).

For pharmacy violations, § 58-17b-504(5) lets DOPL issue a citation , negotiate a stipulated settlement , or start an adjudicative proceeding . The fine may be up to $10,000 per single violation or $2,000 per day of ongoing violation, whichever is greater , following the fine schedule in R156-17b-402 . Examples from that schedule:

  • Violation First offense Subsequent offense
  • Unlicensed practice (§ 58-1-501(1)(a)) $500–$2,000 $2,000–$10,000
  • Buying or selling samples (§ 58-17b-501(4)) $1,000–$5,000 $10,000
  • Accepting back and redistributing dispensed drugs (§ 58-17b-502(1)(e)) $1,000–$5,000 $10,000
  • Pharmacist failing to offer counseling (R156-17b-502(14)(a)) $500–$2,500 $5,000–$10,000

A citation must be contested in writing within 20 calendar days , or it becomes the final order (§ 58-17b-504(5)). Fines go into a dedicated fund for pharmacy licensee education and enforcement (§ 58-17b-505).

The adjudicative process

Complaint and investigation. DOPL investigates. A board member designated under § 58-17b-201(3) may help review the complaint. That member may then be disqualified from hearing the case.

Notice of agency action. DOPL starts an adjudicative proceeding under the Utah Administrative Procedures Act (Title 63G, Chapter 4) and the Department of Commerce rules (§ 58-1-108). Before taking emergency action under § 63G-4-502, DOPL must review it with a committee of at least three licensees appointed by the board chair.

Hearing. The director is the default presiding officer, but an administrative law judge usually conducts formal proceedings, and the licensing board is the fact finder at the evidentiary hearing unless the director specifies otherwise (§ 58-1-109). The fact finder issues a recommended order .

Final order. The director issues a final order that affirms, modifies, or rejects the recommended order, after consulting the presiding officer before modifying or rejecting it. If the director does nothing within 20 calendar days , the recommended order becomes the final order. If the director modifies or rejects the recommendation, the board may, by a two-thirds vote , petition the executive director to review the final order.

Appeal. A party may appeal the director's final order by filing a request for agency review with the executive director of the Department of Commerce (§ 58-1-109(8)), and then seek judicial review.

Time limits

DOPL must start discipline within four years after the conduct is reported , and never more than 10 years after it occurred , unless the proceeding responds to a civil or criminal judgment or settlement and starts within one year of it (§ 58-1-401(6)).